Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
35 studies found for:    " March 06, 2013":" April 05, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" March 06, 2013":" April 05, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Metabolomics Fingerprinting and Metabolic Dynamics After HIV Infection
Condition: HIV
Intervention:
2 Active, not recruiting Prevention of HIV Infection in High-Risk Social Networks of African American Men Who Have Sex With Men (MSM)
Condition: HIV
Interventions: Behavioral: Social Network Intervention;   Behavioral: Counsel, Test, and Treat
3 Active, not recruiting
Has Results
Switching From a TDF-Containing Combination Regimen to a TAF-Containing Fixed Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Positive Participants
Conditions: HIV;   HIV Infections
Interventions: Drug: E/C/F/TAF;   Drug: E/C/F/TDF;   Drug: EFV/FTC/TDF;   Drug: RTV;   Drug: ATV;   Drug: FTC/TDF;   Drug: COBI
4 Completed Statins for Pulmonary and Cardiac Complications of Chronic HIV - Coordinating Center
Condition: HIV Seropositivity
Interventions: Drug: Placebo;   Drug: Rouvastatin calcium
5 Completed
Has Results
Co-receptor Tropism Determination of HIV-1 Subtype A Spread in the Russian Federation Using V3-based Genotyping Tools
Condition: HIV Infection
Intervention:
6 Completed Fluoride Metabolism, Bone Remodelling and Mineral Density in HIV Patients Treated With Tenofovir +/- Emtricitabine
Condition: HIV Seropositivity
Intervention:
7 Active, not recruiting
Has Results
Open-label Safety Study of E/C/F/TAF (Genvoya®) in HIV-1 Positive Patients With Mild to Moderate Renal Impairment
Conditions: HIV;   HIV Infections
Intervention: Drug: E/C/F/TAF
8 Completed A Phase 4 Cross-Sectional Study of Bone Mineral Density in HIV-1 Infected Subjects
Condition: HIV Infections
Intervention:
9 Recruiting Evaluating the Safety and Pharmacokinetics of Raltegravir in Infants
Condition: HIV Infections
Intervention: Drug: Raltegravir
10 Completed Comparison of the QT/QTc Interval Between an Outpatient HIV-Infected Population on Antiretroviral Therapy and Two Large HIV-Negative Cohorts
Condition: QT and Corrected QT Intervals Prolongation in HIV Positive Subjects Treated With an Antiretroviral Regimen
Intervention:
11 Completed Study of Dolutegravir (DTG) on PK of Cenicriviroc (CVC), and CVC on PK of DTG & on a Single Dose of Midazolam
Condition: HIV-infection/AIDS
Interventions: Drug: Cenicriviroc;   Drug: Dolutegravir;   Drug: Midazolam
12 Enrolling by invitation The "START" (a Streamlined ART Initiation Strategy) Study
Condition: HIV
Intervention: Behavioral: START
13 Recruiting Intervention Research to Reduce HIV Sexual Transmission Among HIV Positive Men Who Have Sex With Men
Condition: HIV
Interventions: Behavioral: Gay Poz Sex;   Other: Wait List/Standard of Care
14 Active, not recruiting Immune Enhancement for Immunological Non-responders to ART
Condition: HIV
Intervention: Dietary Supplement: Zinc and SAMe
15 Completed Safety & Immunogenicity of Immunisations With EN41-UGR7C HIV Vaccine
Condition: - HIV
Interventions: Biological: EN41-UGR7C HIV vaccine;   Biological: NaCl
16 Recruiting HIV Test and Treat to Prevent HIV Transmission Among MSM and Transgender Women
Condition: HIV
Intervention: Drug: Atripla or Stribild
17 Withdrawn SCOPE: Strategies to Combine PrEP With Prevention Efforts
Condition: HIV
Intervention: Drug: Once daily Truvada®
18 Completed HCV Treatment in HIV Co-Infected Patients in Asia
Conditions: Hepatitis C;   HIV
Intervention: Drug: Pegylated-Interferon and Ribavirin
19 Completed Conditional Cash Transfers to Increase Uptake of and Retention of PMTCT Services
Condition: HIV
Intervention: Behavioral: Conditional cash transfer
20 Unknown  Impact on T Cell Immune Activation and Inflammation of Triptolide Woldifii in HIV-infected Immunological Non-responders
Condition: HIV
Interventions: Drug: Triptolide;   Drug: cART;   Drug: placebo

   Previous Page Studies Shown (1-20) Next Page (21-35) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.